• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

静脉血红蛋白浓度升高不能用作绝对红细胞增多症的替代标志物:真性红细胞增多症和相对性红细胞增多症患者的研究。

An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.

作者信息

Johansson Peter L, Safai-Kutti Soodabeh, Kutti Jack

机构信息

Haematology and Coagulation Section, Department of Medicine, Sahlgrenska University Hospital, Goteborg, Sweden.

出版信息

Br J Haematol. 2005 Jun;129(5):701-5. doi: 10.1111/j.1365-2141.2005.05517.x.

DOI:10.1111/j.1365-2141.2005.05517.x
PMID:15916693
Abstract

The diagnosis of polycythaemia vera (PV) has been established upon sets of clinical criteria, which require the presence of absolute erythrocytosis (AE). The most recent clinical criteria for PV, published by the World Health Organization (WHO) in 2001, also required AE, and stated that the measured red cell mass (RCM) could be replaced by a surrogate marker for AE; a haemoglobin (Hb) value of >18.5 g/dl in males and >16.5 g/dl in females. The present study evaluated the potential of venous haematocrit (Hct) and Hb values as possible surrogate markers for AE in a series of 77 consecutive patients with PV and 66 patients with apparent polycythaemia (AP), in all of whom the RCM had been previously determined. In only 35% of the male PV patients would Hb values >18.5 g/dl indicate the presence of AE. Conversely, 14% of male AP patients would be misdiagnosed as having AE. A Hb > 16.5 g/dl would predict the presence of AE in 63% of the female PV patients, but 35% of female AP cases would be misdiagnosed as having AE. However, when the Hct was > or =0.60 an AE was always present, and this was true for both male and female subjects.

摘要

真性红细胞增多症(PV)的诊断是基于一系列临床标准确立的,这些标准要求存在绝对红细胞增多症(AE)。世界卫生组织(WHO)于2001年发布的最新PV临床标准也要求有AE,并指出测得的红细胞容量(RCM)可用AE的替代标志物替代;男性血红蛋白(Hb)值>18.5 g/dl,女性>16.5 g/dl。本研究评估了静脉血细胞比容(Hct)和Hb值作为AE可能替代标志物的潜力,研究对象为77例连续的PV患者和66例表观红细胞增多症(AP)患者,所有患者之前均已测定RCM。仅35%的男性PV患者Hb值>18.5 g/dl表明存在AE。相反,14%的男性AP患者会被误诊为有AE。Hb>16.5 g/dl可预测63%的女性PV患者存在AE,但35%的女性AP病例会被误诊为有AE。然而,当Hct≥0.60时总是存在AE,男性和女性受试者均如此。

相似文献

1
An elevated venous haemoglobin concentration cannot be used as a surrogate marker for absolute erythrocytosis: a study of patients with polycythaemia vera and apparent polycythaemia.静脉血红蛋白浓度升高不能用作绝对红细胞增多症的替代标志物:真性红细胞增多症和相对性红细胞增多症患者的研究。
Br J Haematol. 2005 Jun;129(5):701-5. doi: 10.1111/j.1365-2141.2005.05517.x.
2
[Characteristics of diagnostic approach to erythrocytosis of different genesis].[不同成因红细胞增多症的诊断方法特点]
Ter Arkh. 2012;84(4):29-35.
3
Diagnostic value of serum erythropoietin level in patients with absolute erythrocytosis.血清促红细胞生成素水平在真性红细胞增多症患者中的诊断价值。
Haematologica. 2004 Oct;89(10):1194-8.
4
Comparison of diagnostic criteria for polycythaemia vera.真性红细胞增多症诊断标准的比较。
Hematology. 2007 Apr;12(2):123-30. doi: 10.1080/10245330601111797.
5
The WHO diagnostic criteria for polycythemia vera-role of red cell mass versus hemoglobin/hematocrit level and morphology.世界卫生组织真性红细胞增多症诊断标准-红细胞质量与血红蛋白/红细胞压积水平和形态的关系。
Ann Hematol. 2018 Sep;97(9):1581-1590. doi: 10.1007/s00277-018-3344-3. Epub 2018 May 1.
6
Red cell mass, spleen size and plasma erythropoietin in polycythaemia vera and apparent polycythaemia.真性红细胞增多症和相对性红细胞增多症中的红细胞总量、脾脏大小及血浆促红细胞生成素
Acta Haematol. 2002;108(1):1-7. doi: 10.1159/000063064.
7
The value of bone marrow histology in differentiating between early stage Polycythemia vera and secondary (reactive) Polycythemias.骨髓组织学在鉴别早期真性红细胞增多症和继发性(反应性)红细胞增多症中的价值。
Haematologica. 2001 Apr;86(4):368-74.
8
Should whole-body red cell mass be measured or calculated?应该测量还是计算全身红细胞容量?
Blood Cells Mol Dis. 2000 Feb;26(1):25-31; discussion 32-6. doi: 10.1006/bcmd.2000.0272.
9
Familial polycythaemia vera: a study of 3 sisters.
Scand J Haematol. 1976 Jul;17(1):10-6.
10
Characterization of blood donors with high haemoglobin concentration.高血红蛋白浓度献血者的特征描述。
Vox Sang. 2013 Feb;104(2):110-4. doi: 10.1111/j.1423-0410.2012.01644.x. Epub 2012 Aug 15.

引用本文的文献

1
Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?胚系 JAK2 E846D 取代是否是红细胞增多症的原因?
Genes (Basel). 2023 May 11;14(5):1066. doi: 10.3390/genes14051066.
2
Clinical Characteristics of Pediatric Patients with Congenital Erythrocytosis: A Single-Center Study.先天性红细胞增多症患儿的临床特征:一项单中心研究
Indian J Hematol Blood Transfus. 2022 Apr;38(2):366-372. doi: 10.1007/s12288-021-01484-z. Epub 2021 Aug 25.
3
Elevated Hemoglobin and Macrocytosis: A Neglected Association to Become a Diagnostic Tool (A Case Report).
血红蛋白升高伴巨红细胞增多:一个被忽视的诊断工具关联(病例报告)。
Perm J. 2021 May 12;25:20.262. doi: 10.7812/TPP/20.262.
4
Genetic Background of Congenital Erythrocytosis.先天性红细胞增多症的遗传背景。
Genes (Basel). 2021 Jul 28;12(8):1151. doi: 10.3390/genes12081151.
5
Recent Advances in the Use of Molecular Analyses to Inform the Diagnosis and Prognosis of Patients with Polycythaemia Vera.近年来,分子分析在为真性红细胞增多症患者的诊断和预后提供信息方面的应用进展。
Int J Mol Sci. 2021 May 10;22(9):5042. doi: 10.3390/ijms22095042.
6
Diagnosis and management of non-clonal erythrocytosis remains challenging: a single centre clinical experience.非克隆性红细胞增多症的诊断与管理仍具挑战性:单中心临床经验
Ann Hematol. 2021 Aug;100(8):1965-1973. doi: 10.1007/s00277-021-04546-4. Epub 2021 May 19.
7
Juvenile erythrocytosis in children after liver transplantation: prevalence, risk factors and outcome.儿童肝移植后幼年性红细胞增多症:患病率、危险因素和结局。
Sci Rep. 2020 Jun 16;10(1):9683. doi: 10.1038/s41598-020-66586-6.
8
Diagnostic workflow for hereditary erythrocytosis and thrombocytosis.遗传性红细胞增多症和血小板增多症的诊断流程。
Hematology Am Soc Hematol Educ Program. 2019 Dec 6;2019(1):391-396. doi: 10.1182/hematology.2019000047.
9
Time for revival of the red blood cell count and red cell mass in the differential diagnosis between essential thrombocythemia and polycythemia vera?真性红细胞增多症与原发性血小板增多症鉴别诊断中红细胞计数和红细胞量恢复正常的时间?
Haematologica. 2019 Nov;104(11):2119-2125. doi: 10.3324/haematol.2019.229039.
10
Distinguishing essential thrombocythemia V617F from polycythemia vera: limitations of erythrocyte values.区分 V617F 型原发性血小板增多症与真性红细胞增多症:红细胞值的局限性。
Haematologica. 2019 Nov;104(11):2200-2205. doi: 10.3324/haematol.2018.213108. Epub 2019 Apr 4.